379 related articles for article (PubMed ID: 18542120)
1. Endogenous digitalis: pathophysiologic roles and therapeutic applications.
Bagrov AY; Shapiro JI
Nat Clin Pract Nephrol; 2008 Jul; 4(7):378-92. PubMed ID: 18542120
[TBL] [Abstract][Full Text] [Related]
2. Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.
Bagrov AY; Shapiro JI; Fedorova OV
Pharmacol Rev; 2009 Mar; 61(1):9-38. PubMed ID: 19325075
[TBL] [Abstract][Full Text] [Related]
3. Endogenous cardiotonic steroids and salt-sensitive hypertension.
Fedorova OV; Shapiro JI; Bagrov AY
Biochim Biophys Acta; 2010 Dec; 1802(12):1230-6. PubMed ID: 20347967
[TBL] [Abstract][Full Text] [Related]
4. The role of endogenous cardiotonic steroids in pathogenesis of cardiovascular and renal complications of arterial hypertension.
Paczula A; Więcek A; Piecha G
Postepy Hig Med Dosw (Online); 2016 Mar; 70():243-50. PubMed ID: 27117099
[TBL] [Abstract][Full Text] [Related]
5. Endogenous cardiotonic steroids and cardiovascular disease, where to next?
Pavlovic D
Cell Calcium; 2020 Mar; 86():102156. PubMed ID: 31896530
[TBL] [Abstract][Full Text] [Related]
6. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
Bagrov AY; Fedorova OV
J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
[TBL] [Abstract][Full Text] [Related]
7. Endogenous cardiac glycosides, a new class of steroid hormones.
Schoner W
Eur J Biochem; 2002 May; 269(10):2440-8. PubMed ID: 12027881
[TBL] [Abstract][Full Text] [Related]
8. New insights into the regulation of Na+,K+-ATPase by ouabain.
Silva E; Soares-da-Silva P
Int Rev Cell Mol Biol; 2012; 294():99-132. PubMed ID: 22364872
[TBL] [Abstract][Full Text] [Related]
9. [From Digitalis purpurea to toad skin. An historical view of digitalis-like mammalian hormones ].
Ritz E; Schoner W
Dtsch Med Wochenschr; 2008 Dec; 133(51-52):2690-4. PubMed ID: 19067271
[No Abstract] [Full Text] [Related]
10. Endogenous cardiotonic steroids.
Schoner W
Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):273-80. PubMed ID: 11355001
[TBL] [Abstract][Full Text] [Related]
11. Clinical Use of Digitalis: A State of the Art Review.
Whayne TF
Am J Cardiovasc Drugs; 2018 Dec; 18(6):427-440. PubMed ID: 30066080
[TBL] [Abstract][Full Text] [Related]
12. On the differences between ouabain and digitalis glycosides.
Fuerstenwerth H
Am J Ther; 2014; 21(1):35-42. PubMed ID: 21642827
[TBL] [Abstract][Full Text] [Related]
13. Endogenous Mammalian Cardiotonic Steroids-A New Cardiovascular Risk Factor?-A Mini-Review.
Słabiak-Błaż N; Piecha G
Life (Basel); 2021 Jul; 11(8):. PubMed ID: 34440471
[TBL] [Abstract][Full Text] [Related]
14. Endogenous digitalis-like factors. An historical overview.
Buckalew VM
Front Biosci; 2005 Sep; 10():2325-34. PubMed ID: 15970498
[TBL] [Abstract][Full Text] [Related]
15. Advances in understanding the role of cardiac glycosides in control of sodium transport in renal tubules.
Khundmiri SJ
J Endocrinol; 2014 Jul; 222(1):R11-24. PubMed ID: 24781255
[TBL] [Abstract][Full Text] [Related]
16. Chemical models for the chemical nature of endogenous digitalis.
Repke KR; Weiland J; Menke KH
J Enzyme Inhib; 1991; 5(1):25-32. PubMed ID: 1669435
[TBL] [Abstract][Full Text] [Related]
17. Molecular insights into uremic cardiomyopathy: cardiotonic steroids and Na/K ATPase signaling.
Kennedy DJ; Malhotra D; Shapiro JI
Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(8):3-14. PubMed ID: 17535729
[TBL] [Abstract][Full Text] [Related]
18. Endogenous digitalis-like compound in essential hypertension.
Devynck MA; Pernollet MG; De The H; Rosenfeld JB; Meyer P
Proc Eur Dial Transplant Assoc; 1983; 20():489-95. PubMed ID: 6318222
[No Abstract] [Full Text] [Related]
19. Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism.
Bagrov AY; Dmitrieva RI; Dorofeeva NA; Fedorova OV; Lopatin DA; Lakatta EG; Droy-Lefaix MT
J Hypertens; 2000 Feb; 18(2):209-15. PubMed ID: 10694190
[TBL] [Abstract][Full Text] [Related]
20. Endogenous and exogenous cardiac glycosides and their mechanisms of action.
Schoner W; Scheiner-Bobis G
Am J Cardiovasc Drugs; 2007; 7(3):173-89. PubMed ID: 17610345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
